TODD LEROY: Open Payments
NPI 1194350686 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$806 in 47 payments from 8 companies in 2025. Trend: 2023 $635 · 2024 $210 · 2025 $806
Food & beverage: $806
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $213 |
| PFIZER INC. | 8 | $165 |
| Janssen Biotech, Inc. | 9 | $149 |
| Madrigal Pharmaceuticals | 3 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $80 |
| Ardelyx, Inc. | 3 | $48 |
| Phathom Pharmaceuticals, Inc. | 3 | $34 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
Products named: TREMFYA, XELJANZ, REZDIFFRA, RINVOQ, ENTYVIO, SKYRIZI, IBSRELA, VELSIPITY.
Industry payments across FL — which companies pay providers there.
